Fall clinical trials

Explore recruiting fall clinical trials.

Recruiting fall studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fall trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients with Dravet Syndrome

Spain, France, Italy, Poland, Sweden, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term efficacy and tolerability of add-on pramipexole for anhedonic depression – an open label follow-up study

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure (SAFE-LAAC). Comparative Health Effectiveness Randomized Trial – PILOT Study

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Imlifidase in ANCA-associated Vasculitis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Fall trials by city

Fall in Toronto Fall in Vancouver Fall in Montreal Fall in Calgary Fall in Edmonton Fall in Ottawa Fall in Winnipeg Fall in Quebec City Fall in Hamilton Fall in Kitchener Fall in London Fall in Halifax Fall in New York Fall in Los Angeles Fall in Chicago Fall in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease